Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1998 Apr 1;101(7):1458–1467. doi: 10.1172/JCI1841

Plasma and lipids from stored packed red blood cells cause acute lung injury in an animal model.

C C Silliman 1, N F Voelkel 1, J D Allard 1, D J Elzi 1, R M Tuder 1, J L Johnson 1, D R Ambruso 1
PMCID: PMC508724  PMID: 9525989

Abstract

Transfusion-related acute lung injury (TRALI) is a serious complication of hemotherapy. During blood storage, lipids are generated and released into the plasma. In this study, the role of these lipids in TRALI was investigated using an isolated, perfused rat lung model. Rats were pretreated with endotoxin (LPS) or saline in vivo and the lungs were isolated, ventilated, and perfused with saline, or (a) 5% (vol/ vol) fresh human plasma, (b) plasma from stored blood from the day of isolation (D.0) or from the day of outdate (D.42), (c) lipid extracts from D.42 plasma, or (d) purified lysophosphatidylcholines. Lungs from saline or LPS-pretreated rats perfused with fresh (D.0) plasma showed no pulmonary damage as compared with saline perfused controls. LPS pretreatment/D.42 plasma perfusion caused acute lung injury (ALI) manifested by dramatic changes in both pulmonary artery pressure and edema. Incubation of LPS pre-tx rats with mibefradil, a Ca2+ channel blocker, or WEB 2170, a platelet-activating factor (PAF) receptor antagonist, inhibited ALI caused by D.42 plasma. Lung histology showed neutrophil sequestration without ALI with LPS pretreatment/saline or D.0 plasma perfusion, but ALI with LPS pretreatment/D.42 plasma perfusion, and inhibition of D.42 plasma induced ALI with WEB 2170 or mibefradil. A significant increase in leukotriene E4 was present in LPS-pretreated/D.42 plasma-perfused lungs that was inhibited by WEB 2170. Lastly, significant pulmonary edema was produced when lipid extracts of D.42 plasma or lysophosphatidylcholines were perfused into LPS-pretreated lungs. Lipids caused ALI without vasoconstriction, except at the highest dose employed. In conclusion, both plasma and lipids from stored blood produced pulmonary damage in a model of acute lung injury. TRALI, like the adult respiratory distress syndrome, may be the result of two insults: one derived from stored blood and the other from the clinical condition of the patient.

Full Text

The Full Text of this article is available as a PDF (350.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Albelda S. M., Smith C. W., Ward P. A. Adhesion molecules and inflammatory injury. FASEB J. 1994 May;8(8):504–512. [PubMed] [Google Scholar]
  2. Bevilacqua M. P., Nelson R. M. Selectins. J Clin Invest. 1993 Feb;91(2):379–387. doi: 10.1172/JCI116210. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Boxer L. A., Axtell R., Suchard S. The role of the neutrophil in inflammatory diseases of the lung. Blood Cells. 1990;16(1):25–42. [PubMed] [Google Scholar]
  4. Chang S. W., Czartolomna J., Voelkel N. F. Role of eicosanoids in staphylococcal alpha-toxin-induced lung injury in the rat. Am J Physiol. 1992 Apr;262(4 Pt 1):L502–L510. doi: 10.1152/ajplung.1992.262.4.L502. [DOI] [PubMed] [Google Scholar]
  5. Chang S. W., Westcott J. Y., Pickett W. C., Murphy R. C., Voelkel N. F. Endotoxin-induced lung injury in rats: role of eicosanoids. J Appl Physiol (1985) 1989 May;66(5):2407–2418. doi: 10.1152/jappl.1989.66.5.2407. [DOI] [PubMed] [Google Scholar]
  6. Dahlén S. E., Hedqvist P., Hammarström S., Samuelsson B. Leukotrienes are potent constrictors of human bronchi. Nature. 1980 Dec 4;288(5790):484–486. doi: 10.1038/288484a0. [DOI] [PubMed] [Google Scholar]
  7. Detmers P. A., Lo S. K., Olsen-Egbert E., Walz A., Baggiolini M., Cohn Z. A. Neutrophil-activating protein 1/interleukin 8 stimulates the binding activity of the leukocyte adhesion receptor CD11b/CD18 on human neutrophils. J Exp Med. 1990 Apr 1;171(4):1155–1162. doi: 10.1084/jem.171.4.1155. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Fittschen C., Sandhaus R. A., Worthen G. S., Henson P. M. Bacterial lipopolysaccharide enhances chemoattractant-induced elastase secretion by human neutrophils. J Leukoc Biol. 1988 Jun;43(6):547–556. doi: 10.1002/jlb.43.6.547. [DOI] [PubMed] [Google Scholar]
  9. Ford-Hutchinson A. W., Bray M. A., Doig M. V., Shipley M. E., Smith M. J. Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes. Nature. 1980 Jul 17;286(5770):264–265. doi: 10.1038/286264a0. [DOI] [PubMed] [Google Scholar]
  10. Granger D. N., Kubes P. The microcirculation and inflammation: modulation of leukocyte-endothelial cell adhesion. J Leukoc Biol. 1994 May;55(5):662–675. [PubMed] [Google Scholar]
  11. Guthrie L. A., McPhail L. C., Henson P. M., Johnston R. B., Jr Priming of neutrophils for enhanced release of oxygen metabolites by bacterial lipopolysaccharide. Evidence for increased activity of the superoxide-producing enzyme. J Exp Med. 1984 Dec 1;160(6):1656–1671. doi: 10.1084/jem.160.6.1656. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Heddle N. M., Klama L., Singer J., Richards C., Fedak P., Walker I., Kelton J. G. The role of the plasma from platelet concentrates in transfusion reactions. N Engl J Med. 1994 Sep 8;331(10):625–628. doi: 10.1056/NEJM199409083311001. [DOI] [PubMed] [Google Scholar]
  13. Heuer H. O., Casals-Stenzel J., Muacevic G., Weber K. H. Pharmacologic activity of bepafant (WEB 2170), a new and selective hetrazepinoic antagonist of platelet activating factor. J Pharmacol Exp Ther. 1990 Dec;255(3):962–968. [PubMed] [Google Scholar]
  14. Ingraham L. M., Coates T. D., Allen J. M., Higgins C. P., Baehner R. L., Boxer L. A. Metabolic, membrane, and functional responses of human polymorphonuclear leukocytes to platelet-activating factor. Blood. 1982 Jun;59(6):1259–1266. [PubMed] [Google Scholar]
  15. Ingraham L. M., Lafuze J. E., Boxer L. A., Baehner R. L. In vitro and in vivo effects of treatment by platelet-activating factor on N-formyl-met-leu-phe-mediated responses of polymorphonuclear leucocytes. Br J Haematol. 1987 Jun;66(2):219–225. doi: 10.1111/j.1365-2141.1987.tb01302.x. [DOI] [PubMed] [Google Scholar]
  16. Kazanjian P. H., Pennington J. E. Influence of drugs that block calcium channels on the microbicidal function of human neutrophils. J Infect Dis. 1985 Jan;151(1):15–22. doi: 10.1093/infdis/151.1.15. [DOI] [PubMed] [Google Scholar]
  17. Kollef M. H., Schuster D. P. The acute respiratory distress syndrome. N Engl J Med. 1995 Jan 5;332(1):27–37. doi: 10.1056/NEJM199501053320106. [DOI] [PubMed] [Google Scholar]
  18. Krause K. H., Welsh M. J. Voltage-dependent and Ca2(+)-activated ion channels in human neutrophils. J Clin Invest. 1990 Feb;85(2):491–498. doi: 10.1172/JCI114464. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Lynam E. B., Simon S. I., Rochon Y. P., Sklar L. A. Lipopolysaccharide enhances CD11b/CD18 function but inhibits neutrophil aggregation. Blood. 1994 Jun 1;83(11):3303–3311. [PubMed] [Google Scholar]
  20. McPhail L. C., Clayton C. C., Snyderman R. The NADPH oxidase of human polymorphonuclear leukocytes. Evidence for regulation by multiple signals. J Biol Chem. 1984 May 10;259(9):5768–5775. [PubMed] [Google Scholar]
  21. Muylle L., Joos M., Wouters E., De Bock R., Peetermans M. E. Increased tumor necrosis factor alpha (TNF alpha), interleukin 1, and interleukin 6 (IL-6) levels in the plasma of stored platelet concentrates: relationship between TNF alpha and IL-6 levels and febrile transfusion reactions. Transfusion. 1993 Mar;33(3):195–199. doi: 10.1046/j.1537-2995.1993.33393174443.x. [DOI] [PubMed] [Google Scholar]
  22. Muylle L., Wouters E., De Bock R., Peetermans M. E. Reactions to platelet transfusion: the effect of the storage time of the concentrate. Transfus Med. 1992 Dec;2(4):289–293. doi: 10.1111/j.1365-3148.1992.tb00172.x. [DOI] [PubMed] [Google Scholar]
  23. Ono S., Voelkel N. F. PAF antagonists inhibit monocrotaline-induced lung injury and pulmonary hypertension. J Appl Physiol (1985) 1991 Dec;71(6):2483–2492. doi: 10.1152/jappl.1991.71.6.2483. [DOI] [PubMed] [Google Scholar]
  24. Ono S., Westcott J. Y., Voelkel N. F. PAF antagonists inhibit pulmonary vascular remodeling induced by hypobaric hypoxia in rats. J Appl Physiol (1985) 1992 Sep;73(3):1084–1092. doi: 10.1152/jappl.1992.73.3.1084. [DOI] [PubMed] [Google Scholar]
  25. Osterrieder W., Holck M. In vitro pharmacologic profile of Ro 40-5967, a novel Ca2+ channel blocker with potent vasodilator but weak inotropic action. J Cardiovasc Pharmacol. 1989 May;13(5):754–759. [PubMed] [Google Scholar]
  26. Parsons P. E., Fowler A. A., Hyers T. M., Henson P. M. Chemotactic activity in bronchoalveolar lavage fluid from patients with adult respiratory distress syndrome. Am Rev Respir Dis. 1985 Sep;132(3):490–493. doi: 10.1164/arrd.1985.132.3.490. [DOI] [PubMed] [Google Scholar]
  27. Popovsky M. A., Chaplin H. C., Jr, Moore S. B. Transfusion-related acute lung injury. Transfusion. 1993 May;33(5):444–445. doi: 10.1046/j.1537-2995.1993.33593255611.x. [DOI] [PubMed] [Google Scholar]
  28. Popovsky M. A., Moore S. B. Diagnostic and pathogenetic considerations in transfusion-related acute lung injury. Transfusion. 1985 Nov-Dec;25(6):573–577. doi: 10.1046/j.1537-2995.1985.25686071434.x. [DOI] [PubMed] [Google Scholar]
  29. Rabinovici R., Esser K. M., Lysko P. G., Yue T. L., Griswold D. E., Hillegass L. M., Bugelski P. J., Hallenbeck J. M., Feuerstein G. Priming by platelet-activating factor of endotoxin-induced lung injury and cardiovascular shock. Circ Res. 1991 Jul;69(1):12–25. doi: 10.1161/01.res.69.1.12. [DOI] [PubMed] [Google Scholar]
  30. Repine J. E. Scientific perspectives on adult respiratory distress syndrome. Lancet. 1992 Feb 22;339(8791):466–469. doi: 10.1016/0140-6736(92)91067-i. [DOI] [PubMed] [Google Scholar]
  31. Rinaldo J. E., Borovetz H. Deterioration of oxygenation and abnormal lung microvascular permeability during resolution of leukopenia in patients with diffuse lung injury. Am Rev Respir Dis. 1985 Apr;131(4):579–583. doi: 10.1164/arrd.1985.131.4.579. [DOI] [PubMed] [Google Scholar]
  32. Rinaldo J. E., Rogers R. M. Adult respiratory-distress syndrome: changing concepts of lung injury and repair. N Engl J Med. 1982 Apr 15;306(15):900–909. doi: 10.1056/NEJM198204153061504. [DOI] [PubMed] [Google Scholar]
  33. Salzer W. L., McCall C. E. Primed stimulation of isolated perfused rabbit lung by endotoxin and platelet activating factor induces enhanced production of thromboxane and lung injury. J Clin Invest. 1990 Apr;85(4):1135–1143. doi: 10.1172/JCI114545. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Schrenzel J., Demaurex N., Lew D. P., Krause K. H. Caractérisation de l'influx Ca2+ dans les neutrophiles humains par la technique du patch clamp. Schweiz Med Wochenschr. 1995 Jun 10;125(23):1174–1178. [PubMed] [Google Scholar]
  35. Schumann R. R., Pfeil D., Lamping N., Kirschning C., Scherzinger G., Schlag P., Karawajew L., Herrmann F. Lipopolysaccharide induces the rapid tyrosine phosphorylation of the mitogen-activated protein kinases erk-1 and p38 in cultured human vascular endothelial cells requiring the presence of soluble CD14. Blood. 1996 Apr 1;87(7):2805–2814. [PubMed] [Google Scholar]
  36. Seeger W., Schneider U., Kreusler B., von Witzleben E., Walmrath D., Grimminger F., Neppert J. Reproduction of transfusion-related acute lung injury in an ex vivo lung model. Blood. 1990 Oct 1;76(7):1438–1444. [PubMed] [Google Scholar]
  37. Shanwell A., Kristiansson M., Remberger M., Ringdén O. Generation of cytokines in red cell concentrates during storage is prevented by prestorage white cell reduction. Transfusion. 1997 Jul;37(7):678–684. doi: 10.1046/j.1537-2995.1997.37797369441.x. [DOI] [PubMed] [Google Scholar]
  38. Silliman C. C., Clay K. L., Thurman G. W., Johnson C. A., Ambruso D. R. Partial characterization of lipids that develop during the routine storage of blood and prime the neutrophil NADPH oxidase. J Lab Clin Med. 1994 Nov;124(5):684–694. [PMC free article] [PubMed] [Google Scholar]
  39. Silliman C. C., Dickey W. O., Paterson A. J., Thurman G. W., Clay K. L., Johnson C. A., Ambruso D. R. Analysis of the priming activity of lipids generated during routine storage of platelet concentrates. Transfusion. 1996 Feb;36(2):133–139. doi: 10.1046/j.1537-2995.1996.36296181925.x. [DOI] [PubMed] [Google Scholar]
  40. Silliman C. C., Paterson A. J., Dickey W. O., Stroneck D. F., Popovsky M. A., Caldwell S. A., Ambruso D. R. The association of biologically active lipids with the development of transfusion-related acute lung injury: a retrospective study. Transfusion. 1997 Jul;37(7):719–726. doi: 10.1046/j.1537-2995.1997.37797369448.x. [DOI] [PubMed] [Google Scholar]
  41. Sperling R. I., Benincaso A. I., Anderson R. J., Coblyn J. S., Austen K. F., Weinblatt M. E. Acute and chronic suppression of leukotriene B4 synthesis ex vivo in neutrophils from patients with rheumatoid arthritis beginning treatment with methotrexate. Arthritis Rheum. 1992 Apr;35(4):376–384. doi: 10.1002/art.1780350403. [DOI] [PubMed] [Google Scholar]
  42. Stack G., Snyder E. L. Cytokine generation in stored platelet concentrates. Transfusion. 1994 Jan;34(1):20–25. doi: 10.1046/j.1537-2995.1994.34194098597.x. [DOI] [PubMed] [Google Scholar]
  43. Sugawara T., Miyamoto M., Takayama S., Kato M. Separation of neutrophils from blood in human and laboratory animals and comparison of the chemotaxis. J Pharmacol Toxicol Methods. 1995 Apr;33(2):91–100. doi: 10.1016/1056-8719(94)00062-9. [DOI] [PubMed] [Google Scholar]
  44. Tonnesen M. G., Anderson D. C., Springer T. A., Knedler A., Avdi N., Henson P. M. Adherence of neutrophils to cultured human microvascular endothelial cells. Stimulation by chemotactic peptides and lipid mediators and dependence upon the Mac-1, LFA-1, p150,95 glycoprotein family. J Clin Invest. 1989 Feb;83(2):637–646. doi: 10.1172/JCI113928. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Vercellotti G. M., Yin H. Q., Gustafson K. S., Nelson R. D., Jacob H. S. Platelet-activating factor primes neutrophil responses to agonists: role in promoting neutrophil-mediated endothelial damage. Blood. 1988 Apr;71(4):1100–1107. [PubMed] [Google Scholar]
  46. Voelkel N. F., Czartolomna J., Simpson J., Murphy R. C. FMLP causes eicosanoid-dependent vasoconstriction and edema in lungs from endotoxin-primed rats. Am Rev Respir Dis. 1992 Mar;145(3):701–711. doi: 10.1164/ajrccm/145.3.701. [DOI] [PubMed] [Google Scholar]
  47. Véniant M., Clozel J. P., Hess P., Wolfgang R. Ro 40-5967, in contrast to diltiazem, does not reduce left ventricular contractility in rats with chronic myocardial infarction. J Cardiovasc Pharmacol. 1991 Feb;17(2):277–284. doi: 10.1097/00005344-199102000-00014. [DOI] [PubMed] [Google Scholar]
  48. Weiss S. J. Tissue destruction by neutrophils. N Engl J Med. 1989 Feb 9;320(6):365–376. doi: 10.1056/NEJM198902093200606. [DOI] [PubMed] [Google Scholar]
  49. Westcott J. Y., Johnston K., Batt R. A., Wenzel S. E., Voelkel N. F. Measurement of peptidoleukotrienes in biological fluids. J Appl Physiol (1985) 1990 Jun;68(6):2640–2648. doi: 10.1152/jappl.1990.68.6.2640. [DOI] [PubMed] [Google Scholar]
  50. Zimmerman G. A., Renzetti A. D., Hill H. R. Functional and metabolic activity of granulocytes from patients with adult respiratory distress syndrome. Evidence for activated neutrophils in the pulmonary circulation. Am Rev Respir Dis. 1983 Mar;127(3):290–300. doi: 10.1164/arrd.1983.127.3.290. [DOI] [PubMed] [Google Scholar]
  51. Zimmerman J. J., Zuk S. M., Millard J. R. In vitro modulation of human neutrophil superoxide anion generation by various calcium channel antagonists used in ischemia-reperfusion resuscitation. Biochem Pharmacol. 1989 Oct 15;38(20):3601–3610. doi: 10.1016/0006-2952(89)90133-0. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES